Peter H. Ahn

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer

Head and neck squamous cell carcinoma

Clinical development and potential of photothermal and photodynamic therapies for cancer

5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005

Proton Therapy for Head and Neck Cancers

Essential fatty acids in growth and development

Neural Events and the Psychophysical Law

Head and Neck Cancer

Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity

Role of Linoleate as an Essential Fatty Acid for the Cat Independent of Arachidonate Synthesis

Reckless behavior in adolescence: A developmental perspective

The Essential Fatty Acids

Essential fatty acids deficiency in humans

Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin

Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application

HPV, hypoxia and radiation response in head and neck cancer

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Photodynamic therapy in head and neck cancer: indications, outcomes, and future prospects

Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy

Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies

Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes

Treatment of Infantile Fibrosarcoma With Chemotherapy and Surgery: Results From the Dana-Farber Cancer Institute and Children's Hospital, Boston

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial

Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors

Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy

Electrocardiographic Notching in Rats Deficient in Essential Fatty Acids

Sequence of Radiotherapy With Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates